T0	Participants 153 236	individuals with serious mental illness (SMI) receiving antipsychotic drug therapy.
T1	Participants 479 513	individuals with SMI over 8 weeks.
T2	Participants 521 554	30 individuals (BMI â‰¥ 28 kg/m(2))
T3	Participants 672 696	for individuals with SMI
T4	Participants 1328 1373	in patients taking antipsychotic medications;